+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cloning And Mutagenesis Market

  • PDF Icon

    Report

  • 117 Pages
  • December 2022
  • Region: Global
  • Polaris Market Research
  • ID: 5724141
The global cloning and mutagenesis market size is expected to reach USD 9.29 billion by 2030, according to a new study. The report “Cloning And Mutagenesis Market Share, Size, Trends, Industry Analysis Report, By Product (Cloning Kits, Mutagenesis Kits); By Technology; By End-use; By Region; Segment Forecast, 2022 - 2030” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global increase in the DNA and gene cloning services market is driven by the advancement of DNA sequencing technology, its growing application in clinical diagnostics and drug discovery, and an increase in R&D spending. Forensics, reproductive health, customized medicine, biomarkers, and diagnostics are just a few fields in which DNA sequencing is used. Recent research has shown that next-generation sequencing (NGS) technology can quickly and economically find and characterize clinically relevant genetic variations across various genes in a single test. Companies are also providing sequencing services. For instance, in December 2020, Eurofins Genomics introduced cost-effective and optimized SARS-CoV-2 NGS services, enabling the sequencing of the whole viral genome.

The purpose of gene therapy is to treat diseases by modifying genetic material, such as deactivating faulty genes or exchanging a disease-causing gene for a healthy copy. Various illnesses are being treated with gene therapy efficiently. Gene therapy can treat conditions like AIDS, diabetes, cancer, and heart disease.

The market is driven by a strong product portfolio, increased investment by major players, a high prevalence of target diseases, and interest in novel & innovative therapies. However, high product development costs and strict management standards are projected to constrain the global market. Increased R&D spending by public and private institutions is anticipated to open up new prospects in the worldwide cloning and mutagenesis market.

The COVID-19 epidemic has benefited the global market because lockdown measures have been implemented in many nations, which has increased the use of PCR for the detection and analysis of particular gene sequences, which primarily utilizes oligonucleotides as a primer, functioning as a catalyst for industry expansion. Oligonucleotides are widely employed in the biopharmaceutical sector for dsDNA binding, aptamer creation, and allele-specific tests. Moreover, the market is anticipated to present attractive potential in the upcoming years due to the growing utilization of DNA computing, CRISPR gene editing, and mutagenesis investigations.

Cloning And Mutagenesis Market Report Highlights

  • In 2021, the TOPO PCR category dominated the market. TOPO PCR cloning is seeing increased use across a variety of end users, including pharmaceutical and biotech corporations and academic and research institutions.
  • The pharmaceutical and biopharmaceutical companies dominated the revenue in 2021. Pharmaceutical and biopharmaceutical companies are focusing on drug discovery and development due to the rise in disease frequency.
  • North America emerged as the largest regional share in 2021. This substantial percentage can be attributed to the increased demand for biotechnology techniques. Cloning and mutagenesis methods have also become more popular in the region as platforms based on genomic and proteomic data have grown.
  • The global players include Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., New England Biolabs, Takara Bio Inc., Merck KGaA, Promega Corporation, Bio-Rad Laboratories, Inc., Danaher, Jena Bioscience GmbH, Assay Genie, TransGen Biotech Co., Ltd.

The publisher has segmented the cloning and mutagenesis market report based on product, technology, end-use, and region:

Cloning And Mutagenesis, Product Outlook (Revenue - USD Billion, 2018 - 2030)

  • Cloning Kits
  • Mutagenesis Kits

Cloning And Mutagenesis, Technology Outlook (Revenue - USD Billion, 2018 - 2030)

  • TOPO PCR Cloning
  • Site-directed Mutagenesis

Cloning And Mutagenesis, End-Use Outlook (Revenue - USD Billion, 2018 - 2030)

  • Biopharmaceuticals and pharmaceutical companies
  • CROs and CMOS

Cloning And Mutagenesis, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

  • North America
  • U.S
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
Frequently Asked Questions about the Cloning And Mutagenesis Market

What is the estimated value of the Cloning And Mutagenesis Market?

The Cloning And Mutagenesis Market was estimated to be valued at $2.36 billion in 2022.

What is the growth rate of the Cloning And Mutagenesis Market?

The growth rate of the Cloning And Mutagenesis Market is 18.7%, with an estimated value of $9.29 billion by 2030.

What is the forecasted size of the Cloning And Mutagenesis Market?

The Cloning And Mutagenesis Market is estimated to be worth $9.29 billion by 2030.

Who are the key companies in the Cloning And Mutagenesis Market?

Key companies in the Cloning And Mutagenesis Market include Agilent Technologies Inc., Thermo Fisher Scientific Inc., New England Biolabs, Takara Bio Inc., Merck KGaA, Promega Corporation, Bio, Rad Laboratories Inc. and Jena Bioscience GmbH.

Table of Contents

1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary
2.1. Market Highlights

3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources

4. Global Cloning And Mutagenesis Market Insights
4.1. Cloning And Mutagenesis - Industry Snapshot
4.2. Cloning And Mutagenesis Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Rising demand for genetically modified products
4.2.1.2. Increasing demand for personalized medicine
4.2.2. Restraints and Challenges
4.2.2.1. High maintenance cost associated with cloning and mutagenesis tools & instruments
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Cloning And Mutagenesis Market Industry Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Cloning And Mutagenesis Market, by Product
5.1. Key Findings
5.2. Introduction
5.2.1. Global Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
5.3. Cloning Kits
5.3.1. Global Cloning And Mutagenesis Market, by Cloning Kits, by Region, 2018 - 2030 (USD Billion)
5.4. Mutagenesis Kits
5.4.1. Global Cloning And Mutagenesis Market, by Mutagenesis Kits, by Region, 2018 - 2030 (USD Billion)

6. Global Cloning And Mutagenesis Market, by Technology
6.1. Key Findings
6.2. Introduction
6.2.1. Global Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
6.3. TOPO PCR Cloning
6.3.1. Global Cloning And Mutagenesis Market, by TOPO PCR Cloning, by Region, 2018 - 2030 (USD Billion)
6.4. Site-directed Mutagenesis
6.4.1. Global Cloning And Mutagenesis Market, by Site-directed Mutagenesis, by Region, 2018 - 2030 (USD Billion)

7. Global Cloning And Mutagenesis Market, by End-Use
7.1. Key Findings
7.2. Introduction
7.2.1. Global Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
7.3. Biopharmaceuticals and pharmaceutical companies
7.3.1. Global Cloning And Mutagenesis Market, by Biopharmaceuticals and pharmaceutical companies, by Region, 2018 - 2030 (USD Billion)
7.4. CROs and CMOs
7.4.1. Global Cloning And Mutagenesis Market, by CROs and CMOs, by Region, 2018 - 2030 (USD Billion)

8. Global Cloning And Mutagenesis Market, by Geography
8.1. Key findings
8.2. Introduction
8.2.1. Cloning And Mutagenesis Market Assessment, By Geography, 2018 - 2030 (USD Billion)
8.3. Cloning And Mutagenesis Market - North America
8.3.1. North America: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
8.3.2. North America: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
8.3.3. North America: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.3.4. Cloning And Mutagenesis Market - U.S.
8.3.4.1. U.S.: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
8.3.4.2. U.S.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
8.3.4.3. U.S.: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.3.5. Cloning And Mutagenesis Market - Canada
8.3.5.1. Canada: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
8.3.5.2. Canada.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
8.3.5.3. Canada: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.4. Cloning And Mutagenesis Market - Europe
8.4.1. Europe: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
8.4.2. Europe.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
8.4.3. Europe: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.4.4. Cloning And Mutagenesis Market - UK
8.4.4.1. UK: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
8.4.4.2. UK.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
8.4.4.3. UK: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.4.5. Cloning And Mutagenesis Market - France
8.4.5.1. France: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
8.4.5.2. France.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
8.4.5.3. France: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.4.6. Cloning And Mutagenesis Market - Germany
8.4.6.1. Germany: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
8.4.6.2. Germany.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
8.4.6.3. Germany: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.4.7. Cloning And Mutagenesis Market - Italy
8.4.7.1. Italy: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
8.4.7.2. Italy.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
8.4.7.3. Italy: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.4.8. Cloning And Mutagenesis Market - Spain
8.4.8.1. Spain: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
8.4.8.2. Spain.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
8.4.8.3. Spain: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.4.9. Cloning And Mutagenesis Market - Netherlands
8.4.9.1. Netherlands: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
8.4.9.2. Netherlands.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
8.4.9.3. Netherlands: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.4.10. Cloning And Mutagenesis Market - Russia
8.4.10.1. Russia: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
8.4.10.2. Russia.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
8.4.10.3. Russia: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.5. Cloning And Mutagenesis Market - Asia Pacific
8.5.1. Asia Pacific: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
8.5.2. Asia Pacific.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
8.5.3. Asia Pacific: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.5.4. Cloning And Mutagenesis Market - China
8.5.4.1. China: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
8.5.4.2. China.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
8.5.4.3. China: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.5.5. Cloning And Mutagenesis Market - India
8.5.5.1. India: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
8.5.5.2. India.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
8.5.5.3. India: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.5.6. Cloning And Mutagenesis Market - Malaysia
8.5.6.1. Malaysia: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
8.5.6.2. Malaysia.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
8.5.6.3. Malaysia: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.5.7. Cloning And Mutagenesis Market - Japan
8.5.7.1. Japan: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
8.5.7.2. Japan.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
8.5.7.3. Japan: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.5.8. Cloning And Mutagenesis Market - Indonesia
8.5.8.1. Indonesia: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
8.5.8.2. Indonesia.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
8.5.8.3. Indonesia: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.5.9. Cloning And Mutagenesis Market - South Korea
8.5.9.1. South Korea: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
8.5.9.2. South Korea.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
8.5.9.3. South Korea: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.6. Cloning And Mutagenesis Market - Middle East & Africa
8.6.1. Middle East & Africa: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
8.6.2. Middle East & Africa.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
8.6.3. Middle East & Africa: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.6.4. Cloning And Mutagenesis Market - Saudi Arabia
8.6.4.1. Saudi Arabia: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
8.6.4.2. Saudi Arabia.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
8.6.4.3. Saudi Arabia: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.6.5. Cloning And Mutagenesis Market - UAE
8.6.5.1. UAE: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
8.6.5.2. UAE.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
8.6.5.3. UAE: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.6.6. Cloning And Mutagenesis Market - Israel
8.6.6.1. Israel: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
8.6.6.2. Israel.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
8.6.6.3. Israel: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.6.7. Cloning And Mutagenesis Market - South Africa
8.6.7.1. South Africa: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
8.6.7.2. South Africa.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
8.6.7.3. South Africa: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.7. Cloning And Mutagenesis Market - Latin America
8.7.1. Latin America: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
8.7.2. Latin America.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
8.7.3. Latin America: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.7.4. Cloning And Mutagenesis Market - Mexico
8.7.4.1. Mexico: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
8.7.4.2. Mexico.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
8.7.4.3. Mexico: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.7.5. Cloning And Mutagenesis Market - Brazil
8.7.5.1. Brazil: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
8.7.5.2. Brazil.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
8.7.5.3. Brazil: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)
8.7.6. Cloning And Mutagenesis Market - Argentina
8.7.6.1. Argentina: Cloning And Mutagenesis Market, by Product, 2018 - 2030 (USD Billion)
8.7.6.2. Argentina.: Cloning And Mutagenesis Market, by End-Use, 2018 - 2030 (USD Billion)
8.7.6.3. Argentina: Cloning And Mutagenesis Market, by Technology, 2018 - 2030 (USD Billion)

9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles
10.1. Agilent Technologies, Inc
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Recent Development
10.2. Thermo Fisher Scientific, Inc
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Recent Development
10.3. New England Biolabs
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Recent Development
10.4. Takara Bio Inc
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Recent Development
10.5. Merck KGaA
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Recent Development
10.6. Promega Corporation
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Recent Development
10.7. Bio-Rad Laboratories, Inc
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Recent Development
10.8. Danaher
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Recent Development
10.9. Jena Bioscience GmbH
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Recent Development
10.10. Assay Genie
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Recent Development
10.11. TransGen Biotech Co., Ltd
10.11.1. Company Overview
10.11.2. Financial Performance
10.11.3. Product Benchmarking
10.11.4. Recent Development

Companies Mentioned

  • Agilent Technologies Inc.
  • Thermo Fisher Scientific Inc.
  • New England Biolabs
  • Takara Bio Inc.
  • Merck KGaA
  • Promega Corporation
  • Bio-Rad Laboratories Inc.
  • Danaher
  • Jena Bioscience GmbH
  • Assay Genie
  • TransGen Biotech Co. Ltd.